Skip to Main Content
Try STAT+ TODAY
Trending:
The Obesity Revolution
Health
Biotech
STAT+
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Biotech
STAT+

Beam Therapeutics raises $180 million in IPO

By Jonathan Saltzman — Boston GlobeFeb. 6, 2020

Reprints
DNA Editing
Alissa Ambrose/STAT

Beam Therapeutics (BEAM), a Cambridge, Mass., genome-editing startup, raised $180 million in an initial public offering Wednesday after increasing the number of shares it offered to investors by 48 percent.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Jonathan Saltzman — Boston Globe

Tags

Lab tests show risks of using CRISPR gene editing…
Lab tests show risks of using CRISPR gene editing on embryos
‘Essentially witchcraft’: A former naturopath takes on her colleagues
‘Essentially witchcraft’: A former naturopath takes on her colleagues
Why fentanyl is deadlier than heroin, in a single…
Why fentanyl is deadlier than heroin, in a single photo
Biden administration goes easy on Medicare Advantage insurers after…
Biden administration goes easy on Medicare Advantage insurers after intense industry lobbying
European Union drug pricing proposal for the pandemic treaty…
European Union drug pricing proposal for the pandemic treaty generates pushback
Inflation caused a sizable drop in net drug prices…
Inflation caused a sizable drop in net drug prices in late 2022, analysis finds

Recommended Stories